Apogee secures $1.3 billion financing deal with Blackstone for drug development
Tweet Send to a Friend
Apogee Therapeutics Inc. (NASDAQ: APGE) announced a strategic financing collaboration with Blackstone Life Sciences providing up to $1.3 billion in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
